Skip to content

GeneDx Holdings WGS Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$63.32M-870%-$17.67M-$7.64M+8.1%$10.81M+137%-$6.53M+67.7%
$6.81M+19.9%$6.88M+23.8%$6.47M+9.2%$6.19M+18.6%$5.68M+8.2%
$9M+126%$9.78M+244%$10.59M+191%$7.81M+151%$3.98M+983%
-$32.41M-418%$0+100%$15.77M+459%$10.42M+331%$10.18M+162%
$6.45M+5.3%$4.35M+42.5%$6.17M+855%$2.37M+75.2%$6.13M+1,284%
-$17.26M-83.4%-$11.07M-2,033%-$4.69M+39.6%-$36.35M-60.1%-$9.41M-1,216%
$38.59M+181%$23.19M-25.2%$10.77M-22.9%$346K+188%$13.72M+3,232%
-$11.07M-176%$9.03M$21.85M-$25.58M+7.3%$14.49M+191%
-$38.86M-1,059%$9.6M+290%$8.05M+237%$4.05M+124%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does GeneDx Holdings generate?
GeneDx Holdings (WGS) generated -$6.2M in operating cash flow over the trailing twelve months.
What is GeneDx Holdings's free cash flow?
After $19.3M of capital expenditures, GeneDx Holdings's free cash flow was -$17.2M over the trailing twelve months, up 49.5% year over year.
Where does GeneDx Holdings's cash flow data come from?
Every line is extracted from GeneDx Holdings's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.